Transcatheter closure of atrial septal defects

References

• Ebeid MR. Percutaneous catheter closure of secundum atrial septal defects: a review. J. Invasive Cardiol 14, 25–31 (2002).
   PubMedGoogle Scholar
• Rigby ML. The era of transcatheter closure of atrial septal defects. Heart 81, 227–228 (1999).
   PubMedGoogle Scholar
• Schrader R Catheter closure of secundum ASD using 'other' devices. J. Interv. Cardiol 16, 409–412 (2003).
   PubMedGoogle Scholar
• Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children and adults using the Amplatzer septal occluder. J. Interv. Cardiol 14, 37–44 (2001).
   PubMedGoogle Scholar
• ••Reports a large experience with theAmplatzerTM device.
   Google Scholar
• Zahn EM, Wilson N, Cutright W, Latson LA.Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 104, 711–716 (2001).
   PubMedGoogle Scholar
• Carminati M, Chessa M, Butera G et al Transcatheter closure of atrial septal defects with the STARflex device: early results and follow-up. J. Interv. Cardiol 14,319–324 (2001).
   PubMedGoogle Scholar
• Pedra CAC, Pihkala J, Lee KJ et al. Transcatheter closure of atrial septal defects using the CardioSEAL implant. Heart 84, 320–326 (2000).
   PubMedGoogle Scholar
• Rao PS, Berger F, Rey C et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J. Am. Coll. Cardiol 36, 583–592 (2000).
   PubMed Web of Science ®Google Scholar
• Rickers C, Hamm C, Stern H et al. Percutaneous closure of secundum atrial septal defect with a new selfcentering device (AngelWings'). Heart 80, 517–521(1998).
   PubMedGoogle Scholar
• Sievert H, Babic U, Hausdorf G et al. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am. J. Cardiol 82, 1405–1413 (1998).
   PubMed Web of Science ®Google Scholar
• Durongpisitkul K, Tang NL, Soongswang J, Laohaprasitiporn D, Nanal A. Predictors of successful transcatheter closure of atrial septal defect by cardiac magnetic resonance imaging. Pediatr Cardiol 25(2), 124–130 (2004).
   PubMedGoogle Scholar
• Varma C, Benson L, Silversides C et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc. Interv. 61, 131–139 (2004).
   PubMedGoogle Scholar
• Roman KS, Jones A, Keeton BR, Salmon AR Different techniques for closure of multiple interatrial communications with the Amplatzer septal occluder. J. Interv. Cardia 15, 393–397 (2002).
   PubMedGoogle Scholar
• Szkutnik M, Masura J, Bialkowski J et al. Transcatheter closure of double atrial septal defects with a single Amplatzer device. Catheter Cardiovasc. Interv. 61, 237–241 (2004).
   PubMedGoogle Scholar
• Carano N, Hagler DJ, Agnetti A, Squarcia U. Device closure of fenestrated atrial septal defects: use of a single Amplatzer atrial septal occluder after balloon atrial septostomy to create a single defect. Catheter Cardiovasc. Interv. 52, 203–207 (2001).
   PubMedGoogle Scholar
• Rodriguez M, de Lezo JS, Pan M et al. Percutaneous closure of large atrial septal defects. Rev. Esp. Cardiol 56, 888–893 (2003).
   PubMedGoogle Scholar
• de Lezo JS, Medina A, Romero M et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adults with pulmonary hypertension. Am. Heart J. 144, 877–880 (2002).
   PubMed Web of Science ®Google Scholar
• Onorato E, Pera J, Lanzone A et al. Transcatheter treatment of coronary artery disease and atrial septal defect with sequential implantation of coronary stent and Amplatzer septal occluder: preliminary results. Catheter Cardiovasc. Interv. 54, 454–458 (2001).
   PubMed Web of Science ®Google Scholar
• Vogel M, Berger F, Dahnert I, Ewert P, Lange PE. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardia Young 10, 534–537 (2000).
   PubMed Web of Science ®Google Scholar
• Murphy JG, Gersh BJ, McGoon MD et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J. Med. 323, 1645–1650 (1990).
   PubMed Web of Science ®Google Scholar
• Du HD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll Cardiol 39, 1836–1844 (2002).
   PubMed Web of Science ®Google Scholar
• Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J. Thorac. Cardiovasc. Surg. 118, 674–680 (1999).
   PubMedGoogle Scholar
• Thomson JDR, Aburawi EH, Watterson KG, Van Doom C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 87, 466–469 (2002).
   PubMed Web of Science ®Google Scholar
• Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short-term health outcomes of surgical versus device closure of atrial septal defect in children. Heart 87, 67–70 (2002).
   PubMedGoogle Scholar
• Cowley CG, Lloyd TR, Bove EL, Gaffney D, Dietrich M, Rocchini AR Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am. J. Cardiol 88, 589–591 (2001).
   PubMed Web of Science ®Google Scholar
• King TD, Mills NIL. Secundum atrial septal defects: nonoperative closure during cardiac catheterizations. J. Am. Med Assoc. 235, 2506–2509 (1976).
   PubMed Web of Science ®Google Scholar
• Rashkind WJ. Transcatheter treatment of congenital heart diseases. Circulation 67, 711–716 (1983).
   PubMed Web of Science ®Google Scholar
• Babic UU, Grujicic S, Djurisic Z, Vucinic M, Pejcic R Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience. J. Interv. Cardia 4, 283–294 (1991).
   PubMedGoogle Scholar
• Sideris EB, Sideris SE, Fowlkes JP, Ehly RL, Smith JE, Guide RE. Transvenous atrial septal defect occlusion in piglets with a 'buttoned' double disk device. Circulation 81, 312–318 (1990).
   PubMedGoogle Scholar
• Prieto LR, Foreman CK, Cheatham JP Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect using the Bard clamshell septal umbrella. Am. Cardiol 78, 1310–1312 (1996).
   PubMed Web of Science ®Google Scholar
• Das GS, Voss G, Jarvis G, Wyche K, Gunther R, Wilson RE Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation 88, 1754–1764 (1993).
   PubMed Web of Science ®Google Scholar
• Masura J, Gavora P Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet. Cardiovasc. Diagn. 42, 388–393 (1997).
   PubMedGoogle Scholar
• Sideris EB, Leung M, Yoon JH et al. Occlusion of large atrial septal defects with a centering buttoned device: early clinical experience. Am. Heart J. 131, 356–359 (1996).
   PubMedGoogle Scholar
• Latson LA. The CardioSEAL device: history, techniques, results. J. Interv. Cardiol 11, 501–505 (1997).
   Google Scholar
• Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 89, 199–204 (2003).
   PubMed Web of Science ®Google Scholar
• Chessa M, Carminati M, Butera G et al. Early and late complications associated with transcather occlusion of secundum atrial septal defects. J. Am. Coll Cardiol 39, 1061–1065 (2002).
   PubMed Web of Science ®Google Scholar
• Prewitt KC, Gaither NS, Farb A, Wortham DC. Transient ischemic attacks after long-term Clamshell occluder implantation for closure of atrial septal defects. Am. Heart J. 124, 1394–1397(1992).
   PubMedGoogle Scholar
• Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J. Am. Coll Cardid 43, 302–309 (2004).
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of thrombusformation on the various devices, their detection and treatment.
   Google Scholar
• Berger F, Ewert P, Abdul-Khaliq H, Nurnberg JH, Lange PE. Percutaneous closure of large atrial septal defects with the Amplatzer septal occluder: technical overkill or recommendable alternative treatment. J. Interv. Cardiol 14, 63–67 (2001).
   PubMedGoogle Scholar
• Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc. Interv. 58, 246–251 (2003).
   PubMed Web of Science ®Google Scholar
• Ries MW Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am. Heart J. 145,737–731 (2003).
   PubMed Web of Science ®Google Scholar
• Landzberg M, Kbairy P Indications for closure of patent foramen ovale. Heart 90, 219–224 (2004). Provides a good summary of the evidence for closure of patent foramen ovale.
   PubMed Web of Science ®Google Scholar
• Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med. 4, 753–760 (2003).
   Google Scholar
• Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 107,5–9 (2003).
   PubMed Web of Science ®Google Scholar
• Mohr JP, Homma S. Patent cardiac foramen ovale: stroke risk and closure. Ann. Intern. Med 139,787–788 (2003).
   PubMedGoogle Scholar
• Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am. Heart J. 130, 1083–1088 (1995).
   PubMed Web of Science ®Google Scholar
• Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann. Intern. Med. 117, 461–465 (1992).
   PubMed Web of Science ®Google Scholar
• Mohr JP. Cryptogenic stroke. N EngL J. Med. 318, 1197–1198 (1988).
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C et al. Patent foramen ovale and atrial septal aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N EngL J. Med. 345,1740–1746 (2001).
   PubMed Web of Science ®Google Scholar
• De Castro S, Cartoni D, Fiorelli M et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31, 2407–2413 (2000).
   PubMed Web of Science ®Google Scholar
• Knauth M, Ries S, Pohimann S et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. Br. Med. J. 314,701–705 (1997).
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KE Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet 356,1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Cheng TO. Platypnea—orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc. Interv. 47,64–66 (1999).
   PubMed Web of Science ®Google Scholar